XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Organization and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Apr. 04, 2022
USD ($)
Sep. 27, 2024
USD ($)
$ / shares
Mar. 29, 2024
$ / shares
Sep. 29, 2023
USD ($)
$ / shares
Jun. 30, 2023
$ / shares
Mar. 31, 2023
$ / shares
Sep. 27, 2024
USD ($)
segment
Sep. 29, 2023
USD ($)
Dec. 31, 2023
USD ($)
Concentration Risk [Line Items]                  
Number of reportable segments | segment             2    
Quarterly cash dividend declared (in dollars per share) | $ / shares   $ 0.08 $ 0.06 $ 0.06 $ 0.06 $ 0.05      
Payment of dividends             $ 12,135 $ 9,702  
Net income   $ 68,240   $ 57,570     211,098 155,046  
Cumulative translation loss   (1,837,125)         (1,837,125)   $ (1,607,399)
Research and development expense   9,200   $ 9,000     29,000 $ 28,100  
Foreign Currency Translation Adjustment                  
Concentration Risk [Line Items]                  
Cumulative translation loss   119,000         119,000    
Russia                  
Concentration Risk [Line Items]                  
Net income   $ 2,000         $ 12,000    
Russia | Assets | Geographic Concentration Risk                  
Concentration Risk [Line Items]                  
Concentration risk (as a percent)             5.00%    
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk                  
Concentration Risk [Line Items]                  
Concentration risk (as a percent)   6.00%         5.00%    
Enovis Corporation                  
Concentration Risk [Line Items]                  
Cash consideration $ 1,200,000